To showcase the remarkable potential of people with physical disabilities, KAUST Professor Matteo Parsani will travel from the east to the west of Saudi Arabia by hand-bicycle.

An open-source software can help align artificial intelligence applications in healthcare with data privacy regulations.

KAUST Smart-Health Initiative Director and Vice President of Research, Pierre Magistretti, alongside his wife, Christine, wrote a mystery novel that will take you through Europe solving the mysteries of Alzheimer's disease in this Da Vinci Code-esque thriller.

KAUST and NEOM signed a Memorandum Of Understanding to establish collaborative partnerships in the field of smart-health technologies to accelerate impact on health & wellness in the Kingdom of Saudi Arabia.

The discovery of a recent malaria protein by Amit Kumar Subudhi and Professor Arnab Pain could lead to the development of vaccine-like “immune triggers“ for warding off natural malaria infections in people.

Skin organoids offer a powerful platform for drug discovery in the ongoing fight against the virus formerly known as monkeypox.

Comparison of different nuclear magnetic resonance spectroscopy methods has helped to identify the most robust approach for studying different types of biomolecules.

In an article published on Pharmafile.com, KAUST Professor Lukasz Jaremko delves into the promising realm of targeted cancer drug design.

Mutations on a key SARS-CoV-2 viral protein are linked to extreme immune responses and could offer a novel vaccine target.

A complex interplay of factors influences the spread of superbug genes during wastewater treatment and reuse.

Asma Al-Amoodi’s dream of becoming a scientist and working in the lab is coming true as she pursues her Ph.D. in bioscience at KAUST, under the mentorship of Jasmeen Merzaban

KAUST researchers have developed a gene-editing technique that provides a flexible and programmable platform for site-specific gene manipulations across all forms of DNA material.

Drugs that inhibit a key protein should offer new targeted cancer therapy for leukemia and breast cancer.

KAUST’s strategy presents new opportunities to accelerate our positive impact on the world through alignment with the Kingdom’s Vision 2030 Research, Development, and Innovation (RDI) priorities, enhancing our global and local partnerships, and focusing on commercialization and economic impact.

Less hazardous and more sensitive and eco-friendly scintillating compounds could greatly improve X-ray imaging technologies.

Leena Ali Ibrahim’s research is revealing intricate brain connections between the senses that could have implications for finding treatments for autism and schizophrenia.

KAUST researchers work with Saudi hospitals to test novel approaches for early pathogen identification

With his team, Prof. Łukasz Jaremko identified a dynamic behavior of certain proteins that make them potentially useful for targeted cancer therapy.

She was recognized for her groundbreaking work in developing data technology for disease surveillance, which has the ability to detect outbreaks of infectious diseases almost in real time.

Professor Peiying Hong has been honored as one of the four finalists for the prestigious 2023 Letten Prize Award.